Lupin’s arm recalls over 18,000 bottles of Cefdinir in US market
17th Jun 2019

Lupin’s American subsidiary -- Lupin Pharmaceuticals Inc is recalling over 18,000 bottles of Cefdinir for Oral Suspension, used to treat bacterial infections, from the US market. The recalling is due to metal piece identified in the product bottle prior to the reconstitution.

The impacted lot has been manufactured by Lupin's Mandideep manufacturing facility for Baltimore (Maryland) based Lupin Pharmaceuticals Inc.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.